연구성과로 돌아가기
JCR 2022 저널 목록 (803 / 2070)
※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
| Journal Name | Publisher | ISSN | eISSN | Edition | WoS Category | Total Citation | JIF | JIF Quartile | 상위 JCR(%) | JIF % | JIF Rank | 5-Year JIF | 5-Year Quartile | JIF w/o Self-Cites | Immediacy Index | JCI | JCI Rank | JCI Quartile | JCI Percentile | Eigenfactor Score | Normalized Eigenfactor | Article Influence Score | AIS Quartile | Citable Items | Articles in Citable Items (%) | Cited Half-Life | Citing Half-Life | Total Articles | Citable OA (%) | 수집시기 | 바로가기 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Biofuels Bioproducts & Biorefining-Biofpr | WILEY | 1932-104X | 1932-1031 | SCIE | ENERGY & FUELS | 4,474 | 3.9 | Q3 | 58.4 | 41.6 | 70/119 | 4.3 | Q3 | 3.7 | 0.6 | 0.59 | 82/155 | Q3 | 47.42 | 0.003 | 0.649 | 0.676 | Q3 | 115 | 74.8% | 6.0 | 6.3 | 86 | 14.6% | 2025-04-21 09:50:51 | 바로가기 |
| Energy Sources Part B-Economics Planning and Policy | TAYLOR & FRANCIS INC | 1556-7249 | 1556-7257 | SCIE | ENERGY & FUELS | 1,998 | 3.9 | Q3 | 58.4 | 41.6 | 70/119 | 3.2 | Q3 | 3.4 | 0.9 | 0.60 | 81/155 | Q3 | 48.06 | 0.001 | 0.273 | 0.446 | Q3 | 48 | 100.0% | 5.8 | 5.3 | 48 | 10.8% | 2025-04-21 09:50:54 | 바로가기 |
| GEOTHERMICS | PERGAMON-ELSEVIER SCIENCE LTD | 0375-6505 | 1879-3576 | SCIE | ENERGY & FUELS | 7,593 | 3.9 | Q3 | 58.4 | 41.6 | 70/119 | 4.4 | Q3 | 3.3 | 0.8 | 0.86 | 62/155 | Q2 | 60.32 | 0.006 | 1.321 | 0.823 | Q2 | 236 | 98.7% | 5.9 | 9.8 | 233 | 23.3% | 2025-04-21 09:50:49 | 바로가기 |
| Indian Journal of Psychiatry | WOLTERS KLUWER MEDKNOW PUBLICATIONS | 0019-5545 | 1998-3794 | SCIE | PSYCHIATRY | 3,438 | 3.1 | Q3 | 58.4 | 41.6 | 91/155 | 2.7 | Q3 | 3.0 | 0.3 | 0.52 | 170/264 | Q3 | 35.80 | 0.003 | 0.669 | 0.623 | Q4 | 99 | 93.9% | 7.3 | 8.8 | 93 | 98.7% | 2025-04-21 10:28:45 | 바로가기 |
| International Journal of Greenhouse Gas Control | ELSEVIER SCI LTD | 1750-5836 | 1878-0148 | SCIE | ENERGY & FUELS | 13,164 | 3.9 | Q3 | 58.4 | 41.6 | 70/119 | 4.1 | Q3 | 3.5 | 1.1 | 0.57 | 84/155 | Q3 | 46.13 | 0.008 | 1.786 | 0.741 | Q3 | 199 | 97.5% | 7.0 | 8.0 | 194 | 33.0% | 2025-04-21 09:50:47 | 바로가기 |
| International Journal of Lean Six Sigma | EMERALD GROUP PUBLISHING LTD | 2040-4166 | 2040-4174 | SSCI | MANAGEMENT | 1,631 | 4.0 | Q3 | 58.4 | 41.6 | 133/227 | 4.3 | Q3 | 3.4 | 0.8 | 0.84 | 158/401 | Q2 | 60.72 | 0.001 | 0.207 | 0.472 | Q4 | 55 | 89.1% | 4.1 | 6.9 | 49 | 8.5% | 2025-04-21 10:10:29 | 바로가기 |
| INTERNATIONAL JOURNAL OF METHODS IN PSYCHIATRIC RESEARCH | WILEY | 1049-8931 | 1557-0657 | SCIE | PSYCHIATRY | 4,235 | 3.1 | Q3 | 58.4 | 41.6 | 91/155 | 4.3 | Q2 | 2.9 | 0.5 | 0.83 | 104/264 | Q2 | 60.80 | 0.003 | 0.653 | 1.345 | Q2 | 46 | 93.5% | 11.4 | 8.3 | 43 | 67.7% | 2025-04-21 10:28:44 | 바로가기 |
| Journal of Psychosomatic Obstetrics & Gynecology | TAYLOR & FRANCIS LTD | 0167-482X | 1743-8942 | SCIE | PSYCHIATRY | 2,192 | 3.1 | Q3 | 58.4 | 41.6 | 91/155 | 3.2 | Q3 | 3.0 | 0.4 | 0.87 | 94/264 | Q2 | 64.58 | 0.002 | 0.373 | 0.790 | Q3 | 25 | 92.0% | 10.2 | 6.4 | 23 | 9.5% | 2025-04-21 10:28:48 | 바로가기 |
| WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY | TAYLOR & FRANCIS LTD | 1562-2975 | 1814-1412 | SCIE | PSYCHIATRY | 3,109 | 3.1 | Q3 | 58.4 | 41.6 | 91/155 | 3.3 | Q3 | 3.0 | 1.4 | 0.66 | 136/264 | Q3 | 48.67 | 0.003 | 0.567 | 0.839 | Q3 | 72 | 83.3% | 7.6 | 8.2 | 60 | 16.3% | 2025-04-21 10:28:46 | 바로가기 |
| World Journal of Psychiatry | BAISHIDENG PUBLISHING GROUP INC | 2220-3206 | 2220-3206 | SCIE | PSYCHIATRY | 1,656 | 3.1 | Q3 | 58.4 | 41.6 | 91/155 | 4.2 | Q2 | 2.9 | 1.0 | 0.52 | 170/264 | Q3 | 35.80 | 0.002 | 0.344 | 1.085 | Q3 | 88 | 46.6% | 6.1 | 8.0 | 41 | 100.0% | 2025-04-21 10:28:50 | 바로가기 |
| ANNALS OF PHARMACOTHERAPY | SAGE PUBLICATIONS INC | 1060-0280 | 1542-6270 | SCIE | PHARMACOLOGY & PHARMACY | 7,707 | 2.9 | Q3 | 58.5 | 41.5 | 163/278 | 2.9 | Q3 | 2.9 | 0.5 | 0.53 | 227/366 | Q3 | 38.11 | 0.005 | 1.171 | 0.817 | Q2 | 141 | 61.0% | 11.0 | 5.6 | 86 | 2.0% | 2025-04-21 10:24:16 | 바로가기 |
| BMC Pharmacology & Toxicology | BMC | N/A | 2050-6511 | SCIE | PHARMACOLOGY & PHARMACY | 1,963 | 2.9 | Q3 | 58.5 | 41.5 | 163/278 | 2.9 | Q3 | 2.9 | 0.5 | 0.74 | 148/366 | Q2 | 59.70 | 0.002 | 0.451 | 0.568 | Q3 | 95 | 97.9% | 4.8 | 7.8 | 93 | 99.6% | 2025-04-21 10:24:33 | 바로가기 |
| CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY | WILEY | 0305-1870 | 1440-1681 | SCIE | PHARMACOLOGY & PHARMACY | 7,012 | 2.9 | Q3 | 58.5 | 41.5 | 163/278 | 2.8 | Q3 | 2.9 | 0.6 | 0.75 | 145/366 | Q2 | 60.52 | 0.004 | 0.790 | 0.489 | Q3 | 108 | 84.3% | 10.1 | 7.0 | 91 | 4.8% | 2025-04-21 10:24:17 | 바로가기 |
| Drug Testing and Analysis | WILEY | 1942-7603 | 1942-7611 | SCIE | PHARMACOLOGY & PHARMACY | 4,243 | 2.9 | Q3 | 58.5 | 41.5 | 163/278 | 2.7 | Q3 | 2.2 | 1.0 | 0.79 | 134/366 | Q2 | 63.52 | 0.004 | 0.923 | 0.506 | Q3 | 170 | 94.7% | 4.7 | 6.7 | 161 | 24.2% | 2025-04-21 10:24:22 | 바로가기 |
| EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY | SPRINGER HEIDELBERG | 0031-6970 | 1432-1041 | SCIE | PHARMACOLOGY & PHARMACY | 8,611 | 2.9 | Q3 | 58.5 | 41.5 | 163/278 | 2.8 | Q3 | 2.8 | 0.6 | 0.64 | 181/366 | Q2 | 50.68 | 0.006 | 1.225 | 0.704 | Q2 | 162 | 74.1% | 9.7 | 7.1 | 120 | 32.1% | 2025-04-21 10:24:15 | 바로가기 |
페이지 이동: